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1  | INTRODUCTION
Infections following transplantation are associated with reduced pa-
tient and allograft survival at 1 and 3 years after transplantation.1,2 
The incidence of post- transplant peritonitis in peritoneal dialysis 
(PD) patients ranges from 8% to 43%.3-5 Given that PD patients 
have a 50% higher adjusted odds of receiving a kidney transplant 
when compared to hemodialysis (HD) patients,6 the management 
of PD catheters at the time of transplant could have a significant 
impact on patient and graft outcome. However, current guidelines 
are somewhat ambiguous regarding the management of the PD 
catheter post- transplant.7-10 Studies in pediatric patients suggested 
PD catheter use after transplantation was an effective treatment 
without infectious complications.10-12 European Best Practice 
Guidelines state “The catheter can be left in situ 3- 4 months despite 
a functioning graft; nevertheless, earlier removal after successful 
transplantation is advisable.”7 However, there is literature demon-
strating increased incidence of infection, longer hospitalization, and 
increased risk for rejection associated with PD post- transplant.13 
No prospective studies have been performed to address PD cath-
eter management around the time of kidney transplantation. The 
purpose of this study was to compare outcomes of PD patients who 
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Abstract
Objective: Peritoneal dialysis (PD) patients have equivalent or slightly better kidney 
transplant outcomes when compared to hemodialysis (HD) patients. However, given 
the risk for postoperative infection, we sought to determine the risk factors for PD 
catheter- associated infections for patients who do not have the PD catheter removed 
at the time of engraftment.
Methods: Demographic and outcomes data were collected from 313 sequential PD 
patients who underwent kidney transplant from 2000 to 2015. Risk factors for post-
operative peritonitis were analyzed using logistical regression.
Results: Of 329 patients with PD catheters at transplant, 16 PD catheters were re-
moved at engraftment. Of the remaining 313 patients, 8.9% suffered post- transplant 
peritonitis. On univariate analysis, patients with peritonitis were significantly more 
likely to have used the PD catheter or HD within 6 weeks after transplant. Multivariate 
analysis had similar findings, with increased risk for those using the PD catheter after 
transplant, with a trend for those who underwent HD only within 6 weeks of 
transplant.
Conclusion: These results suggest that delayed graft function requiring any type of 
dialysis is associated with increased post- transplant peritonitis risk.
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had PD catheters removed after their transplant surgery and iden-
tify risk factors for peritonitis.
2  | METHODS
A retrospective chart review was performed among 329 consecutive 
PD patients who had their primary kidney alone transplanted at the 
University of Michigan Transplantation Center between 2000 and 2015. 
End- stage renal disease patients greater than 18 years of age with PD 
as their dialysis modality at the time of transplantation between 2000 
and 2015 were included in the study. Three hundred thirteen patients 
were included for analyses. Sixteen patients were excluded due to PD 
catheter removed at the time of engraftment based on surgeon prefer-
ence and risk for delayed graft function. Patients were followed up for 
6 weeks after transplantation for peritonitis and 365 days for patient 
mortality and graft loss/return to dialysis. There were six patient deaths 
with a functioning graft and no graft failures during the study period. 
Perioperative antibiotic prophylaxis, typically cefazolin, was utilized in 
accordance with center protocol. Post- transplant infectious prophy-
laxis included anti-Pneumocystis and anti-cytomegalovirus agents.
There were 136 recipients of living donor transplants and 177 
recipients of deceased donor transplants. All patients had PD cath-
eters managed by their primary nephrologist. Operative notes were 
reviewed to identify whether there was compromise of the peritoneal 
cavity during engraftment of the transplant. Ureteral stents were rou-
tinely used and removed by 6 weeks post- transplant.
Standard immunosuppression included an induction agent and 
maintenance with a calcineurin inhibitor, mycophenolate mofetil or 
mycophenolic acid, and prednisone. Induction with thymoglobulin was 
administered in patients for high degree of sensitization (PRA > 20%, 
African American race, recipient of living unrelated transplant, pa-
tient undergoing desensitization or ABO incompatible transplant, 
patients <65 years old and receiving an extended criteria kidney, pos-
itive cross match due to donor- specific antibody or other anti- HLA 
antibody, presence of donor- specific antibody on any pretransplant 
sera regardless of cross match). Otherwise, patients were inducted 
with methyl prednisolone without polyclonal or monoclonal antibody 
agents. In patients with delayed graft function, defined as requiring 
dialysis within the first week of transplant at our center, thymoglob-
ulin at induction dosing was added post- transplant. Otherwise, there 
is no difference in the management of maintenance immunosuppres-
sion between patients with delayed graft function and immediate graft 
function.
The definition of peritonitis was based on that published by the 
International Society of Peritoneal Dialysis: peritonitis was identified 
based on peritoneal fluid white blood cell count greater than 100/
μL with at least 50% polymorphonuclear neutrophilic cells, a positive 
peritoneal fluid culture, or signs and symptoms of peritonitis based on 
clinical assessment.14 However, given that peritoneal signs are not re-
liably present on immunosuppressed patients, particularly those who 
have recently had induction immunosuppression, the absence of clini-
cal signs or symptoms was not considered reliable for the purposes of 
this study. However, PD fluid samples were only collected if there was 
clinical concern for peritonitis or infection, fulfilling the last criterion 
for the diagnosis of peritonitis. Peritoneal fluid samples were collected 
under sterile conditions after a dwell of 2 hours by PD nurses when 
the physician has concern for peritonitis. Peritoneal fluid collection 
was obtained based on clinical concern for peritonitis.
2.1 | Statistical analysis
Demographic risk factors for peritonitis including age, race, body mass 
index (BMI), dialysis vintage (months), primary cause of ESRD, history 
of peritonitis, living vs deceased donor, induction therapy, docu-
mented peritoneum damage during operation, and dialysis modality 
at the time of transplant were obtained. Analyses were performed to 
determine risk factors for peritonitis in patients whose PD catheter 
remained in place postoperatively, compared to those who were re-
moved intraoperatively.
Descriptive statistics were used to calculate percentages for di-
chotomous variables, and median with respective 25th to 75th per-
centiles for continuous variables. Categorical variables were compared 
using chi- square test. Continuous variables with normal distributions 
were compared using independent sample t test, while the Mann- 
Whitney U tests were used to compare continuous variables that had 
non- normal distributions. An initial univariate logistic regression anal-
ysis was performed, and all variables found to have a P-	value	of	≤.20	




Age 48 (37- 58)
Female sex N = 140 (42.5%)
BMI at first contact 28 (24.78- 32.33)
BMI > 30 124 (37.7%)
African American 51 (16.3%)
Caucasian 242 (77.3%)
Dialysis vintage (months) 62 (26- 137)
Primary cause of ESRD
Hypertension 49 (14.9%)
Diabetes 93 (28.3%)






Living related 73 (22.2%)
Living unrelated 79 (24.0%)
Deceased 177 (53.8%)
Data listed as median (Q1- Q3) or number of cases (%).
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were two- tailed, and a P-	value	 of	 ≤.05	 was	 considered	 significant	
throughout the analysis. Statistical analyses were performed using 
SAS version 9.3 (SAS Institute, Cary, NC, USA). The study protocol 
was approved by the institutional review board at the University of 
Michigan (IRB #HUM00010092).
3  | RESULTS
Three hundred thirteen patients were included in the outcomes 
analysis. Demographic and clinical background data for the cohort 
of patients are shown in Table 1. The median age of the population 
was 48 years old (range: 37- 58), and 58% of the patients were male. 
Seventy- seven percent of the patients were Caucasian, and 16% 
were African American. The median BMI was 28, and 38% of patients 
had BMI greater than 30. The most common primary cause of ESRD 
was diabetes (28.3% patients). The median duration of PD catheter 
use prior to transplantation was 630 days. For those who kept their 
catheter postoperatively, the median time to removal of the perito-
neal catheter was 25 days after transplantation. Forty- nine (15.7%) 
patients required dialysis within 6 weeks post- transplantation. There 
were six deaths during the first year post- transplant, but only one of 
these deaths was within 90 days. One patient death occurred with 
peritonitis listed as the cause of death.
There were 28 documented episodes of peritonitis in the 313 
patients who did not have their peritoneal catheters removed at the 
time of transplant, 13 based on cell count and 15 episodes based on 
culture. Forty- six percent (13/28) were culture negative, 18% (5/28) 
were due to coagulase- negative Staphylococcus, and 11% (3/28) were 
due to methicillin- resistant Staphylococcus aureus. The microbiologic 
organisms responsible for peritonitis are shown in Table 2.
Of the 49 patients requiring dialysis within the first 6 weeks post- 
transplant, 17 underwent HD using only a HD catheter or other vas-
cular access, 16 utilized a dialysis catheter or other vascular access but 
had a PD catheter in place, and 33 utilized their existing PD catheter 
at some point for dialysis during of the first 6 weeks post- transplant, 
although they may have utilized HD for a portion of that time. There 
were no PD catheters placed for dialysis within the study period.
Risk factors associated with peritonitis in primary kidney trans-
plant patients with PD catheters after transplantation were identi-
fied using univariate logistic regression. The results are presented 
in Table 3. PD catheter use within the first 6 weeks post- transplant 
(OR 3.46; 95% CI: 1.26, 9.4810- 9.60; P = .02), HD catheter use 
within 6 weeks (OR 4.6, 95% CI: 1.34, 15.77, P = .02), HD or PD 
dialysis within the first 6 weeks post- transplant (OR 5.18; 95% CI: 
1.71, 15.74; P = .004) showed a statistically significant increased 
risk.
A pretransplant history of PD- associated peritonitis, HD within 
the first 6 weeks postoperatively, and PD use only within the first 
6 weeks postoperatively were included in a multivariate analysis; 
“either HD or PD within 6 weeks” was excluded from the multi-
variate analysis, as it includes both other dialysis categories. The 
multivariate model had similar findings to the univariate analysis. 
PD catheter use within the first 6 weeks post- transplant showed 
a statistically significant rise in risk (OR 3.68; 95% CI: 1.21, 11.19, 
P = .02). A trend toward significance was seen for patients who 
underwent HD within the first 6 weeks (OR 5.532; 95% CI: 0.94, 
30.54; P = .06). A history of peritonitis was not a significant risk 
factor for developing peritonitis post- transplant (OR 2.24; 95% CI: 
0.73, 6.85; P = .16).
TABLE  2 Peritoneal fluid culture results
PD culture Frequency
No growth 13
Coagulase (- ) Staphylococcus 5
Methicillin- resistant Staphylococcus aureus 3
Pseudomonas aeruginosa 2
Vancomycin- resistant Enterococcus 1




TABLE  3 Risk factors for peritonitis post- transplant
Characteristic Odds ratio 95% CI P- value
Age at transplant 
(years)
1.01 0.98, 1.05 .40
Non- Caucasian race 0.75 0.25, 2.30 .61
Female 1.06 0.45, 2.48 .90
BMI 1.02 0.98, 1.06 .38
Dialysis vintage 
(months)
1.004 0.99, 1.02 .56
DM as cause of 
ESRD




2.05 0.71, 5.90 .19
History of exit site 
infection
<0.001 <0.001, >999 .9858
Number of kidney 
transplants
1.94 0.90, 4.15 .09
Deceased donor 1.55 0.64, 3.78 .34
Any induction agent 1.37 0.49, 3.85 .55
Antithymocyte 
antibody induction
1.30 0.53, 3.21 .57
Renal biopsy within 
6 wk
1.49 0.64, 3.49 .36
Either HD or PD 
within 6 wk
5.18 1.71, 15.74 .004
PD catheter use 
within 6 wka
3.46 1.26, 9.48 .02
HD catheter use 
within 6 wka
4.60 1.34, 15.77 .02
aVariables included in the multivariable analysis.
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4  | DISCUSSION
There was an 8.9% rate of peritonitis in this patient population, which 
is lower than what has been reported in some of the literature.13,15,16 
Similar to the results from Warren et al,3 we found that patients 
requiring postoperative dialysis due to DGF had increased risk of 
peritonitis. In this study, either HD or PD within the first 6 weeks 
post- transplant was associated with a threefold to fivefold risk for 
peritonitis. Forty- six percent of the postoperative peritonitis episodes 
were culture negative and diagnosed based on cell count. Almost 30% 
of the peritonitis episodes were caused by staphylococcal infections. 
Peritoneal breach documented in operative reports was not associ-
ated with peritonitis. Staphylococcal infections have been associated 
with previous tunnel or exit site infections.4 These patients could also 
have altered flora due to the immunosuppression administered for 
their transplant or be nasal carriers of Staphylococcus.
Similar to Molnar et al,17 almost 16% of our patients required dial-
ysis within the first 6 weeks post- transplantation. Sixty- seven percent 
of the patients requiring dialysis had HD, with almost 35% dialyz-
ing with either a HD catheter or other vascular access without a PD 
catheter present, and almost 33% dialyzing with either a HD catheter 
or other vascular access with a PD catheter in place. The use of PD 
catheter at any time within the first 6 weeks post- transplantation was 
independently associated with an increased risk for peritonitis, when 
compared to those who did not use their PD catheters post- transplant.
Patients with slow graft function or DGF have more infections for 
multiple reasons, including prolonged hospitalization, dialysis require-
ment, and additional immunosuppressive therapy. A study by Gonwa 
et al18 outlined that patients with slow graft function or DGF had a 
longer length of stay and required more postoperative HD. Guimaraes- 
Souza et al19 noted that patients with slow graft function or DGF had 
higher rates of infection than patients with immediate graft function. 
Our findings were consistent with the risk factors identified in this 
study.
This study has limitations. It is a single center study, with ret-
rospective design. The center’s PD catheter management protocol 
was to leave the catheters in place at the time of surgery until April 
of 2015. There may be differences in the patients before and after 
the change in the protocol that are not accounted for. There have 
been significant improvements in electronic storage of records, 
which may result in a difference in data fidelity for patients who 
were transplanted before and after the change in the data collecting 
mechanisms in the different electronic medical records. The retro-
spective design also limited our ability to determine the clinical in-
dications for collection of peritoneal fluid for examination or to fully 
assess for false positives (eg, colonization). When combined with 
the unreliability of an abdominal examination for peritoneal signs in 
patients who have recently had induction immunosuppression, we 
chose to define peritonitis as having a WBC count of >100 cells/
μL in peritoneal fluid collected from patients with clinical suspicion 
for peritonitis. Furthermore, given the small number of patients 
with peritonitis, we might not be able to appreciate many of the 
risk factors for peritonitis in this single center study. With a larger, 
multicenter cohort, it is possible that further associations would 
emerge. The risk of peritonitis is impacted by the use of the PD 
catheter and possible peritoneal breach during kidney engraftment. 
While the former is available, the latter was not found to be reliably 
recorded in the operative record. Different practice patterns have 
existed over time, and among individual transplant nephrologists, on 
the willingness to use the PD catheter early after transplant, which 
could also impact the results. Finally, while this study was designed 
to evaluate risk factors for peritonitis associated with PD catheter 
presence post- transplant, HD catheters also pose a significant risk 
for infectious complications. As the utility of a PD catheter post- 
transplant is dependent not just on a risk- benefit analysis, but also 
on the local protocol or willingness to utilize the catheter, the appli-
cability of this study will vary center to center.
In summary, post- transplant peritonitis diagnoses were rare. 
However, factors associated with dialysis requirement post- 
transplant placed patients with an indwelling PD catheter at an 
increased risk of peritonitis. Most patients requiring dialysis post- 
transplantation utilized HD as the primary modality in addition to 
PD, which placed patients at an increased risk for postoperative 
peritonitis. Given those practice patterns, PD catheter removal at 
the time of transplantation is a reasonable approach to care for 
these patients.
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